Results 111 to 120 of about 1,521,521 (318)
Total domination numbers of cartesian products
Let $G\Box H$ denote the cartesian product of graphs G and H. Here we determine the total domination numbers of $P_5\Box P_n$ and $P_6\Box P_n$.
openaire +4 more sources
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Total outer-connected domination number of middle graphs [PDF]
Farshad Kazemnejad +3 more
openalex +1 more source
Total domination number of grid graphs
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
openaire +1 more source
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source
On the total domatic number of regular graphs [PDF]
A set S of vertices of a graph G = (V;E) without isolated vertex is a total dominating set if every vertex of V (G) is adjacent to some vertex in S.
H. Aram +2 more
doaj
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir +12 more
wiley +1 more source
Lower bounds on the signed (total) $k$-domination number depending on the clique number
Let $G$ be a graph with vertex set $V(G)$. For any integer $k\ge 1$, a signed (total) $k$-dominating function is a function $f: V(G) \rightarrow \{ -1, 1\}$ satisfying $\sum_{x\in N[v]}f(x)\ge k$ ($\sum_{x\in N(v)}f(x)\ge k$) for every $v ...
L. Volkmann
doaj +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source

